[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"content-doc-dcio87b1ed1d":3},{"user":4,"document":8,"mainDocument":27,"columnUrl":29,"subscription":30,"footer":42,"text":77},{"isAuthenticated":5,"isAdmin":5,"displayName":6,"avatarUrl":6,"nid":6,"groupLevel":7},false,"",-10,{"id":9,"fullTitle":10,"subTitle":6,"url":11,"columnId":12,"columnName":13,"columnUrl":14,"summary":6,"contentHtml":15,"mainContentHtml":6,"posterUrl":16,"createDate":17,"displayDate":18,"displayDateSlash":19,"pageviews":20,"tags":21,"hidden":5,"isSubContent":5,"replyDocOrTargetId":6,"contentType":23,"videoId":6,"liveVideoUrl":6,"duration":24,"price":24,"priceText":25,"priceBadgeText":25,"priceBadgeClass":26,"freeForMinGroupLevel":24,"redirectUrl":6,"readyToStream":5},"dcio87b1ed1d","67亿美元拿下Terns(TERN)！默沙东(MRK)加码抗癌管线应对Keytruda专利到期","\u002Fdoc\u002Fdcio87b1ed1d","col18178739ee","美股资讯","\u002Fcol\u002Fcol18178739ee","\u003Cp>&nbsp;\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-size:large;\">美股投资网获悉，默沙东(MRK)周三宣布，将以67亿美元收购生物技术公司Terns Pharmaceuticals(TERN)。目前，这家制药巨头正加紧扩充其癌症药物产品线，以应对旗下重磅疗法Keytruda即将面临的专利到期问题。\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-size:large;\">这家美国制药商将在本十年晚些时候失去Keytruda的专利保护，最早明年还可能面临政府主导的价格谈判。自2021年以来，默沙东通过自主研发及大手笔收购——包括以115亿美元购入拥有肺动脉高压药物Winrevair的Acceleron——已将其后期研发管线规模扩大近两倍。\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-size:large;\">此次收购将使默沙东获得Terns旗下实验性药物TERN-701。该药物正被测试用于治疗慢性髓性白血病——一种起源于骨髓、导致白血病细胞失控增殖的癌症。\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-size:large;\">默沙东对Terns提出的收购价为每股53美元，较其最新收盘价溢价6%。截至发稿，Terns股价在盘前交易时段上涨逾5%。\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-size:large;\">在一项早期研究中，TERN-701在既往接受过治疗的白血病患者中显示出75%的主要分子生物学缓解率。分析人士认为，这一结果使其有望成为诺华制药(NVS)白血病药物Scemblix的潜在替代产品。\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-size:large;\">2024年3月，美国食品药品监督管理局已授予TERN-701用于治疗慢性髓性白血病的孤儿药资格。\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-size:large;\">该交易预计将于今年第二季度完成，届时将产生约58亿美元(合每股约2.35美元)的费用，这笔费用将分别计入季度及全年财务业绩中。\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-size:large;\">默沙东董事长兼首席执行官Robert M. Davis表示“此次收购Terns及TERN-701，进一步巩固了我们在血液学领域的影响力。TERN-701有望成为治疗特定慢性髓性白血病患者的同类最佳候选药物。这笔交易不仅进一步拓展并强化了我们在肿瘤学领域的布局，我们也将继续寻求机会，将产品组合拓展至其他治疗领域。”\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-size:large;\">据了解，默沙东的主要增长引擎Keytruda获批用于治疗多种癌症，是全球最畅销的处方药。该疗法在2025年创下逾300亿美元的销售额，占公司总营收的近半壁江山。\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-size:large;\">上月，默沙东已宣布计划将肿瘤业务拆分为独立部门。\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-size:large;\">最专业的美股资讯推荐美股大数据 \u003C\u002Fspan>\u003Ca target=\"_blank\" rel=\"noopener noreferrer\" href=\"https:\u002F\u002FStockwe.com\u002F\">\u003Cspan style=\"font-size:large;\">https:\u002F\u002FStockwe.com\u002F\u003C\u002Fspan>\u003C\u002Fa>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-size:large;\">如何识别美股市场异常波动？美国机构主力资金买卖情况，出货和吸筹，使用美股投资网VIP会员，2008年成立于美国硅谷，由前纽约证券交易所分析师Ken创立，联合多位摩根斯坦利分析师，谷歌 Meta工程师利用AI和大数据，配合十多年美股实战经验和业内量化模型，建立了一个股市数据库 \u003C\u002Fspan>\u003Ca target=\"_blank\" rel=\"noopener noreferrer\" href=\"https:\u002F\u002FStockWe.com\u002F\">\u003Cspan style=\"font-size:large;\">https:\u002F\u002FStockWe.com\u002F\u003C\u002Fspan>\u003C\u002Fa>\u003Cspan style=\"font-size:large;\"> 每天处理千万级股票数据：捕捉期权大单，实时主力资金流向、机构持仓变化、川普突发新闻，精准交易信号第一时间发到您手机APP！\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>&nbsp;\u003C\u002Fp>","https:\u002F\u002Fwww.tradesmax.com\u002Fimages\u002Fa_Stock\u002FT\u002FTER\u002FTER.jpg","2026-03-25T13:59:24","2026.03.25","2026\u002F03\u002F25",38154,[22],"TERN","Article",0,"免费","success",{"id":9,"fullTitle":10,"subTitle":6,"url":11,"columnId":12,"columnName":13,"columnUrl":14,"summary":6,"contentHtml":15,"mainContentHtml":6,"posterUrl":16,"createDate":17,"displayDate":18,"displayDateSlash":19,"pageviews":20,"tags":28,"hidden":5,"isSubContent":5,"replyDocOrTargetId":6,"contentType":23,"videoId":6,"liveVideoUrl":6,"duration":24,"price":24,"priceText":25,"priceBadgeText":25,"priceBadgeClass":26,"freeForMinGroupLevel":24,"redirectUrl":6,"readyToStream":5},[22],"\u002Fcol\u002Fstocknews",{"visible":5,"marketingHtml":31,"services":32,"recentDocuments":41},"\u003Cfigure class=\"image\">\u003Ca href=\"https:\u002F\u002Fstockwe.com\u002Fdoc\u002Fdcio537efad5\" target=\"_blank\" rel=\"noopener noreferrer\">\u003Cimg style=\"display:block;margin-left:auto;margin-right:auto;\" src=\"https:\u002F\u002Fstockwewebfiles.blob.core.windows.net\u002Fweb-202408-stk\u002F1586109431mceclip0.jpg\">\u003C\u002Fa>\u003C\u002Ffigure>\u003Cdiv class=\"text-center\">\u003Ch2 class=\"card-title mx-auto\">\u003Cbr>\u003Ca target=\"_blank\" rel=\"noopener noreferrer\" href=\"https:\u002F\u002Fstockwe.com\u002Fdoc\u002Fdcio537efad5\">案例介绍：英伟达深度研究报告\u003C\u002Fa>\u003C\u002Fh2>\u003C\u002Fdiv>",[33,37],{"productId":34,"serviceName":35,"priceText":36},"prod_PPxdDdK87QaiLv","月付","$12.95美元",{"productId":38,"serviceName":39,"priceText":40},"prod_PPxeMs3bix1da5","年付","$149.00美元",[],{"links":43,"images":68,"summaryHtml":73,"aboutTitle":74,"aboutHtml":75,"copyrightHtml":76},[44,47,50,53,56,59,62,65],{"label":45,"url":46},"深度报告","\u002Fcol\u002FdepthReport",{"label":48,"url":49},"VIP会员","\u002Fplan",{"label":51,"url":52},"期权推荐","\u002FOption",{"label":54,"url":55},"低价暴涨股","\u002FPenny",{"label":57,"url":58},"常见问题","https:\u002F\u002Fstockwe.com\u002FFAQ",{"label":60,"url":61},"美股课程","\u002Fcol\u002Fvideos",{"label":63,"url":64},"免责声明","\u002Fdisclaimer",{"label":66,"url":67},"联系我们","\u002FContactUs",[69,70,71,72],"https:\u002F\u002Fstockwebsiteblob.blob.core.windows.net\u002Fweb-202509-stk\u002FUploaderzic2tuwsol2_2025_09_11_18_21_07.gif","https:\u002F\u002Fstockwebsiteblob.blob.core.windows.net\u002Fweb-202509-stk\u002FUploadercakzdvydksw_2025_09_03_09_00_56.png","https:\u002F\u002Fstockwebsiteblob.blob.core.windows.net\u002Fweb-202509-stk\u002FUploadergtjyagwvoyk_2025_09_14_08_32_05.png","https:\u002F\u002Fstockwebsiteblob.blob.core.windows.net\u002Fweb-202509-stk\u002FUploader3u0tt4jhlqh_2025_09_23_22_30_48.png","邮箱: buy@TradesMax.com 美国电话 626-378-3637","公司介绍","\u003Cp class=\"MsoNormal\">美股大数据 StockWe.com 是一个美国领先的金融和美股信息大数据提供商，紧盯华尔街金融市场和行情，2008年成立于美国硅谷，创始人是前纽约证券交易所资深分析师Ken，联合多位摩根斯坦利分析师，谷歌 Meta工程师利用AI和大数据，配合十多年美股实战经验和业内量化交易模型，每天处理千万级股票数据：挖掘潜力大牛股，捕捉期权异动大单，实时主力资金流向、机构持仓变化、川普突发新闻，精准买卖信号第一时间发到您手机APP。\u003C\u002Fp>","专业美股投资者都在这里",{"loading":78,"search":79,"searchPlaceholder":79,"hotContent":80,"draft":81,"noData":82,"searchNoData":83,"edit":84,"editVideo":85,"courseContent":86,"more":87,"buyNow":88,"subscribeNow":89,"encoding":90,"paidContent":91},"Loading...","搜索","热门内容","草稿","目前没有任何内容公布","当前检索内容没有数据","编辑","编辑视频","课程内容","更多","立即购买后观看","- 立即订阅 -","视频编码中...","付费内容"]